Assessment of the cell-mediated immunity induced by alphavirus replicon-vectored DNA vaccines against classical swine fever in a mouse model

Veterinary Immunology and Immunopathology

Volumn 129, Issue 1-2, 2009, Pages 57-65

  Zhao, He Ping ^a   Sun, Jian Fu ^a,b   Li, Na ^a   Sun, Yuan ^a   Xia, Zhao He ^a   Wang, Yu ^a   Cheng, Dan ^a   Qi, Qiao Fen ^a   Jin, Mei Lin ^a,b   Qiu, Hua Ji ^a  

^a Harbin Veterinary Research Institute   (China)

^b YANBIAN UNIVERSITY   (China)

Author keywords

Alphavirus replicon vector; Cell mediated immunity (CMI); Classical swine fever virus (CSFV); VP22

Indexed keywords

CYTOKINE; DNA VACCINE; HYBRID PROTEIN;

ALPHA VIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELLULAR IMMUNITY; CLINICAL ASSESSMENT; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL MOUSE; FEMALE; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PSEUDORABIES; SWINE DISEASE; VIRUS REPLICATION;

ANIMALS; ANTIBODIES, VIRAL; CLASSICAL SWINE FEVER; CLASSICAL SWINE FEVER VIRUS; DISEASE MODELS, ANIMAL; FEMALE; IMMUNITY, CELLULAR; IMMUNIZATION; INTERFERON-GAMMA; INTERLEUKIN-4; MICE; MICE, INBRED BALB C; PLASMIDS; REPLICON; SWINE; VACCINES, DNA; VIRAL ENVELOPE PROTEINS; VIRAL VACCINES;

ALPHAVIRUS; ANIMALIA; CLASSICAL SWINE FEVER VIRUS; SUID HERPESVIRUS 1; SUIDAE;

EID: 62549124077     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetimm.2008.12.011     Document Type: Article

References (38)

1. Aints A., Dilber M.S., and Smith C.I. Intercellular spread of GFP-VP22. J. Gene Med. 1 (1999) 275-279
2. Bird J.J., Brown D.R., Mullen A.C., Moskowitz N.H., Mahowald M.A., Sider J.R., Gajewski T.F., Wang C.R., and Reiner S.L. Helper T cell differentiation is controlled by the cell cycle. Immunity 9 (1998) 229-237
3. Chakrabarti S., Brechling K., and Moss B. Vaccinia virus expression vector: coexpression of beta-galactosidase provides visual screening of recombinant virus plaques. Mol. Cell. Biol. 5 (1985) 3403-3409
4. Cheng W.F., Hung C.H., Chai C.Y., Hsu K.F., He L., Ling M., and Wu T.C. Enhancement of Sindbis virus self-replicating RNA vaccine potency by linkage of herpes simplex virus type 1 VP22 protein to antigen. J. Virol. 75 (2001) 2368-2376
5. Dong X.N., and Chen Y.H. Marker vaccine strategies and candidate CSFV marker vaccines. Vaccine 25 (2007) 205-230
6. Elliott G., and O'Hare P. Intercellular trafficking of VP22-GFP fusion proteins. Gene Ther. 6 (1999) 145-151
7. Fang B., Xu B., Koch P., and Roth J.A. Intercellular trafficking of VP22-GFP fusion proteins is not observed in cultured mammalian cells. Gene Ther. 5 (1998) 1420-1424
8. Ford K.G., Souberbielle B.E., Darling D., and Farzaneh F. Protein transduction: an alternative to genetic intervention?. Gene Ther. 8 (2001) 1-4
9. Ganges L., Barrera M., Nunez J.I., Blanco I., Frias M.T., Rodríguez F., and Sobrino F. A DNA vaccine expressing the E2 protein of classical swine fever virus elicits T cell responses that can prime for rapid antibody production and confer total protection upon viral challenge. Vaccine 23 (2005) 3741-3752
10. Greiser-Wilke I., Blome S., and Moennig V. Diagnostic methods for detection of classical swine fever virus-status quo and new developments. Vaccine 25 (2007) 5524-5530
11. Harms J.S., Ren X., Oliveira S.C., and Splitter G.A. Distinctions between bovine herpesvirus 1 and herpes simplex virus type 1 VP22 tegument protein subcellular associations. J. Virol. 74 (2000) 3301-3312
12. Hung C.F., Cheng W.F., Chai C.Y., Hsu K.F., He L., Ling M., and Wu T.C. Improving vaccine potency through intercellular spreading and enhanced MHC class I presentation of antigen. J. Immunol. 166 (2001) 5733-5740
13. Hung C.F., He L., Juang J., Lin T.J., Ling M., and Wu T.C. Improving DNA vaccine potency by linking Marek's disease virus type 1 VP22 to an antigen. J. Virol. 76 (2002) 2676-2682
14. Kim S.J., Sung H.W., Han J.H., Jackwood D., and Kwon H.M. Protection against very virulent infectious bursal disease virus in chickens immunized with DNA vaccines. Vet. Microbiol. 101 (2004) 39-51
15. Leitner W., Ying H., Driver D.A., Dubensky T.W., and Restifo N.P. Enhancement of tumor-specific immune response with plasmid DNA replicon vectors. Cancer Res. 60 (2000) 51-55
16. Li N., Qiu H.J., Zhao J.J., Li Y., Wang M.J., Lu B.W., Han C.G., Hou Q., Wang Z.H., Gao H., Peng W.P., Li G.X., Zhu Q.H., and Tong G.Z. A Semliki Forest virus replicon vectored DNA vaccine expressing the E2 glycoprotein of classical swine fever virus protects pigs from lethal challenge. Vaccine 25 (2007) 2907-2912
17. Li N., Zhao J.J., Zhao H.P., Sun Y., Zhu Q.H., Tong G.Z., and Qiu H.J. Protection of pigs from lethal challenge by a DNA vaccine based on an alphavirus replicon expressing the E2 glycoprotein of classical swine fever virus. J. Virol. Methods 144 (2007) 73-78
18. Liu D., Yu J., Chen H., Reichman R., Wu H., and Jin X. Statistical determination of threshold for cellular division in the CFSE-labeling assay. J. Immunol. Methods 312 (2006) 126-136
19. Meyers G., and Thiel H.J. Molecular characterization of pestiviruses. Adv. Virus Res. 47 (1996) 53-118
20. Michel N., Osen W., Gissmann L., Schumacher T.N., Zentgraf H., and Müller M. Enhanced immunogenicity of HPV 16 E7 fusion proteins in DNA vaccination. Virology 294 (2002) 47-59
21. Miyamoto T., Min W., and Lillehoj H.S. Lymphocyte proliferation response during Eimeria tenella infection assessed by new, reliable nonradioactive colorimetric assay. Avian Dis. 46 (2002) 10-16
22. Moennig V. Introduction to classical swine fever virus, disease and control policy. Vet. Microbiol. 73 (2000) 93-102
23. Moormann R.J., Van Gennip H.G., Miedema G.K., Hulst M.M., and van Rijn P.A. Infectious RNA transcribed from an engineered full-length cDNA template of the genome of a pestivirus. J. Virol. 70 (1996) 763-770
24. Nordström E.K., Forsell M.N., Barnfield C., Bonin E., Hanke T., Sundström M., Karlsson G.B., and Liljeström P. Enhanced immunogenicity using an alphavirus replicon DNA vaccine against human immunodeficiency virus type 1. J. Gen. Virol. 86 (2005) 349-354
25. Oliveira S.C., Harms J.S., Afonso R.R., and Splitter G.A. A genetic immunization adjuvant system based on BVP22-antigen fusion. Hum. Gene Ther. 12 (2001) 1353-1359
26. Oran A.E., and Robinson H.L. DNA vaccines: influenza virus challenge of a Th2/Tc2 immune response results in a Th2/Tc1 response in the lung. J. Virol. 78 (2004) 4376-4380
27. Peng W.P., Xia Z.H., Hou Q., Li N., Sun Y., Tong G.Z., and Qiu H.J. Differences in glycosylation of the E2 protein between virulent Shimen strain and a virulent C-strain of classical swine fever virus. Bing Du Xue Bao 23 (2007) 389-393 Chinese
28. Perkins S.D., Hartley M.G., Lukaszewski R.A., Phillpotts R.J., Stevenson F.K., and Bennett A.M. VP22 enhances antibody responses from DNA vaccines but not by intercellular spread. Vaccine 23 (2005) 1931-1940
29. Prescott L.M. Microbiology. 5th edition (2002), McGraw Hill, New York 336
30. Quah B.J., Warren H.S., and Parish C.R. Monitoring lymphocyte proliferation in vitro and in vivo with the intracellular fluorescent dye carboxyfluorescein diacetate succinimidyl ester. Nat. Protoc. 2 (2007) 2049-2056
31. Saha S., Yoshida S., Ohba K., Matsui K., Matsuda T., Takeshita F., Umeda K., Tamura Y., Okuda K., Klinman D., Xin K.Q., and Okuda K. A fused gene of nucleoprotein (NP) and herpes simplex virus genes (VP22) induces highly protective immunity against different subtypes of influenza virus. Virology 354 (2006) 48-57
32. Suradhat S., Damrongwatanapokin S., and Thanawongnuwech R. Factors critical for successful vaccination against classical swine fever in endemic areas. Vet. Microbiol. 119 (2007) 1-9
33. Umezu-Goto M., Kishi Y., Taira A., Hama K., Dohmae N., Takio K., Yamori T., Mills G.B., Inoue K., Aoki J., and Arai H. Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production. J. Cell. Biol. 158 (2002) 197-199
34. van Oirschot J.T. Vaccinology of classical swine fever: from lab to field. Vet. Microbiol. 96 (2003) 367-384
35. Voigt H., Merant C., Wienhold D., Braun A., Hutet E., Le Potier M.F., Saalmüller A., Pfaff E., and Büttner M. Efficient priming against classical swine fever with a safe glycoprotein E2 expressing Orf virus recombinant (ORFV VrV-E2). Vaccine 25 (2007) 5915-5926
36. + cytotoxic T lymphocytes. J. Immunol. Methods 276 (2003) 45-47
37. Zheng C.F., Babiuk L.A., and van Drunen Littel-van den Hurk S. Bovine herpesvirus 1 VP22 enhances the efficacy of a DNA vaccine in cattle. J. Virol. 79 (2005) 1948-1953
38. Zheng C.F., Brownlie R., Huang D.Y., Babiuk L.A., and van Drunen Littel-van den Hurk S. Intercellular trafficking of the major tegument protein VP22 of bovine herpesvirus-1 and its application to improve a DNA vaccine. Arch. Virol. 151 (2006) 985-993